Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...